Read More Pharma Industry News Biocon Generics acquires US facility for $7.7m, targets two billion tablet capacity Biocon Limited, a global leader in the biopharmaceutical industry, has made a landmark announcement: its wholly-owned subsidiary, Biocon… byPallavi MadhirajuSeptember 2, 2023